An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer. - Liu, Joyce; Burris, Howard; Wang, Judy S.; Barroilhet, Lisa; Gutierrez, Martin; Wang, Yulei; Vaze, Anjali; Commerford, Renee; Royer-Joo, Stephanie; Choeurng, Voleak; Humke, Eric; Moore, Kathleen (Gynecologic Oncology, 2021)